Immunoadjuvant activity of the nanoparticles' surface modified with mannan

Nanotechnology

Volumn 25, Issue 35, 2014, Pages

  Haddadi, Azita ^a   Hamdy, Samar ^b   Ghotbi, Zahra ^b   Samuel, John ^b   Lavasanifar, Afsaneh ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

dendritic cells; immunoadjuvant; mannan; nanoparticle; PLGA; vaccine

Indexed keywords

CELLS; NANOPARTICLES; VACCINES;

BIOLOGICAL FUNCTIONS; DENDRITIC CELLS; DENDRITIC CELLS (DCS); IMMUNOADJUVANTS; MANNAN; PHYSICAL ADSORPTION; PLGA; POLY(D ,L-LACTIDE-CO-GLYCOLIDE);

COPOLYMERS;

BIOLOGICAL MARKER; CYTOKINE; IMMUNOLOGICAL ADJUVANT; LACTIC ACID; MANNAN; NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CHEMISTRY; DENDRITIC CELL; DRUG EFFECTS; IMMUNITY; IMMUNOLOGY; MALE; MEDICINAL CHEMISTRY; METABOLISM; MOUSE; PROCEDURES; T LYMPHOCYTE; UPREGULATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BIOLOGICAL MARKERS; CHEMISTRY, PHARMACEUTICAL; CYTOKINES; DENDRITIC CELLS; IMMUNITY; LACTIC ACID; MALE; MANNANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NANOPARTICLES; POLYGLYCOLIC ACID; T-LYMPHOCYTES; UP-REGULATION;

EID: 84906087828     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/25/35/355101     Document Type: Article

References (51)

1. Foged C, Sundblad A and Hovgaard L 2002 Targeting vaccines to dendritic cells Pharm. Res. 19 229-38 (Pubitemid 34211837)
2. Elamanchili P, Lutsiak C M, Hamdy S, Diwan M and Samuel J 2007 Pathogen-mimicking nanoparticles for vaccine delivery to dendritic cells J. Immunother. 30 378-95 (Pubitemid 46684428)
3. Hamdy S, Elamanchili P, Alshamsan A, Molavi O, Satou T and Samuel J 2007 Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles J. Biomed. Mater. Res. A 81 652-62 (Pubitemid 46786896)
4. Kerrigan A M and Brown G D 2009 C-type lectins and phagocytosis Immunobiology 214 562-75
5. Vinogradov E, Petersen B and Bock K 1998 Structural analysis of the intact polysaccharide mannan from Saccharomyces cerevisiae yeast using 1 H and 13C NMR spectroscopy at 750 MHz Carbohydr. Res. 307 177-83 (Pubitemid 28282862)
6. White K L, Rades T, Furneaux R H, Tyler P C and Hook S 2006 Mannosylated liposomes as antigen delivery vehicles for targeting to dendritic cells J. Pharm. Pharmacol. 58 729-37 (Pubitemid 43836160)
7. Autenrieth S E and Autenrieth I B 2009 Variable antigen uptake due to different expression of the macrophage mannose receptor by dendritic cells in various inbred mouse strains Immunology 127 523-9
8. Burgdorf S, Lukacs-Kornek V and Kurts C 2006 The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation J. Immunol. 176 6770-6 (Pubitemid 43787859)
9. Apostolopoulos V, Barnes N, Pietersz G A and McKenzie I F 2000 targeting of the macrophage mannose receptor generates anti-tumor CTL responses Ex vivo 18 3174-84 (Pubitemid 30348658)
10. Taylor P R, Gordon S and Martinez-Pomares L 2005 The mannose receptor: linking homeostasis and immunity through sugar recognition Trends Immunol. 26 104-10
11. Engering A J, Cella M, Fluitsma D, Brockhaus M, Hoefsmit E C, Lanzavecchia A and Pieters J 1997 The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells Eur. J. Immunol. 27 2417-25 (Pubitemid 27404329)
12. Stahl P D and Ezekowitz R A 1998 The mannose receptor is a pattern recognition receptor involved in host defense Curr. Opin. Immunol. 10 50-5 (Pubitemid 28112079)
13. Keler T, Ramakrishna V and Fanger M W 2004 Mannose receptor-targeted vaccines Expert Opin. Biol. Ther. 4 1953-62 (Pubitemid 39627146)
14. Presicce P, Taddeo A, Conti A, Villa M L and Della Bella S 2008 Keyhole limpet hemocyanin induces the activation and maturation of human dendritic cells through the involvement of mannose receptor Mol. Immunol. 45 1136-45 (Pubitemid 350016326)
15. Cambi A, Netea M G, Mora-Montes H M, Gow N A, Hato S V, Lowman D W, Kullberg B J, Torensma R, Williams D L and Figdor C G 2008 Dendritic cell interaction with Candida albicans critically depends on N-linked mannan J. Biol. Chem. 283 20590-9
16. Cai C, Mao S, Germershaus O, Schaper A, Rytting E, Chen D and Kissel T 2009 Influence of morphology and drug distribution on the release process of FITC-dextran-loaded microspheres prepared with different types of PLGA J. Microencapsul. 26 334-5
17. Budhian A, Siegel S J and Winey K I 2005 Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol J. Microencapsul. 22 773-85 (Pubitemid 43158197)
18. Jaklenec A, Hinckfuss A, Bilgen B, Ciombor D M, Aaron R and Mathiowitz E 2008 Sequential release of bioactive IGF-I and TGF-beta 1 from PLGA microsphere-based scaffolds Biomaterials 29 1518-25
19. Nagata S, Takeshima K, Hirano K and Takagishi Y 1994 Pharmaceutical dosage form design of copoly (lactic/glycolic acid) microspheres. Mechanism of in vitro release of gentamicin Yakugaku Zasshi: J. Pharm. Soc. Japan 114 1005-14
20. Takada S and Ogawa Y 1998 Design and development of controlled release of drugs from injectable microcapsules Nihon Rinsho. 56 675-9
21. Gasper M M, Blanco D, Cruz M E and Alonso M J 1998 Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release J. Control Release 52 53-62 (Pubitemid 28123172)
22. Luan X and Bodmeier R 2006 Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems J. Control Release 110 266-72 (Pubitemid 41827479)
23. van de Weert M, Hennink W E and Jiskoot W 2000 Protein instability in poly(lactic-co-glycolic acid) microparticles Pharm. Res. 17 1159-67
24. Ghotbi Z, Haddadi A, Hamdy S, Hung R W, Samuel J and Lavasanifar A 2011 Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles J. Drug Target 19 281-92
25. Haddadi A, Elamanchili P, Lavasanifar A, Das S, Shapiro J and Samuel J 2008 Delivery of rapamycin by PLGA nanoparticles enhances its suppressive activity on dendritic cells J. Biomed. Mater. Res. A 84 885-98 (Pubitemid 351294999)
26. Kocbek P, Obermajer N, Cegnar M, Kos J and Kristl J 2007 Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody J. Control Release 120 18-26 (Pubitemid 46874614)
27. Lutz M B, Kukutsch N, Ogilvie A L, Rossner S, Koch F, Romani N and Schuler G 1999 An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow J. Immunol. Methods 223 77-92 (Pubitemid 29096240)
28. Lutsiak M E, Robinson D R, Coester C, Kwon G S and Samuel J 2002 Analysis of poly(D,L-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro Pharm. Res. 19 1480-7 (Pubitemid 35266552)
29. Jalil R and Nixon J R 1990 Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties J. Microencapsul. 7 297-325 (Pubitemid 20336774)
30. Newman K D, Sosnowski D L, Kwon G S and Samuel J 1998 Delivery of MUC1 mucin peptide by Poly(d,l-lactic-co-glycolic acid) microspheres induces type 1 T helper immune responses J. Pharm. Sci. 87 1421-7
31. Newman K D, Samuel J and Kwon G 1998 Ovalbumin peptide encapsulated in poly(d,l lactic-co-glycolic acid) microspheres is capable of inducing a T helper type 1 immune response J. Control Release 54 49-59 (Pubitemid 28255237)
32. Ma J, Luo D, Kwon G S, Samuel J, Noujaim A A and Madiyalakan R 1998 Use of encapsulated single chain antibodies for induction of anti-idiotypic humoral and cellular immune responses J. Pharm. Sci. 87 1375-8
33. Ma J, Samuel J, Kwon G S, Noujaim A A and Madiyalakan R 1998 Induction of anti-idiotypic humoral and cellular immune responses by a murine monoclonal antibody recognizing the ovarian carcinoma antigen CA125 encapsulated in biodegradable microspheres Cancer Immunol. Immunother. 47 13-20 (Pubitemid 28430526)
34. Wang D, Robinson D R, Kwon G S and Samuel J 1999 Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery J. Control Release 57 9-18 (Pubitemid 29005068)
35. Partidos C D, Vohra P, Anagnostopoulou C, Jones D H, Farrar G H and Steward M W 1996 Biodegradable microparticles as a delivery system for measles virus cytotoxic T cell epitopes Mol. Immunol. 33 485-91 (Pubitemid 26228385)
36. Partidos C D, Vohra P, Jones D H, Farrar G H and Steward M W 1996 Mucosal immunization with a measles virus CTL epitope encapsulated in biodegradable PLG microparticles J. Immunol. Methods 195 135-8 (Pubitemid 26292696)
37. Nixon D F et al 1996 Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity Vaccine 14 1523-30 (Pubitemid 27023496)
38. Moore G D and Croxatto H B 1988 Synthetic microspheres transferred to the rat oviduct on day 1 of pregnancy mimic the transport of native ova J. Reprod. Fertil. 82 735-42 (Pubitemid 18083042)
39. Kempf M, Mandal B, Jilek S, Thiele L, Voros J, Textor M, Merkle H P and Walter E 2003 Improved stimulation of human dendritic cells by receptor engagement with surface-modified microparticles J. Drug Target 11 11-8 (Pubitemid 36527391)
40. Cruz L J, Tacken P J, Fokkink R, Joosten B, Stuart M C, Albericio F, Torensma R and Figdor C G 2010 Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro J. Control Release 144 118-26
41. Dominguez A L and Lustgarten J 2010 Targeting the tumor microenvironment with anti-neu/anti-CD40 conjugated nanoparticles for the induction of antitumor immune responses Vaccine 28 1383-90
42. Yoo M K, Park I Y, Kim I Y, Park I K, Kwon J S, Jeong H J, Jeong Y Y and Cho C S 2008 Superparamagnetic iron oxide nanoparticles coated with mannan for macrophage targeting J. Nanosci. Nanotechnol. 8 5196-202
43. Kaur A, Jain S and Tiwary A K 2008 Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: in vitro and in vivo evaluation Acta Pharm. 58 61-74 (Pubitemid 351419158)
44. Sheng K C, Kalkanidis M, Pouniotis D S, Esparon S, Tang C K, Apostolopoulos V and Pietersz G A 2008 Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo Eur. J. Immunol. 38 424-36
45. Jiang H L, Kang M L, Quan J S, Kang S G, Akaike T, Yoo H S and Cho C S 2008 The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization Biomaterials 29 1931-9
46. Cui Z, Han S J and Huang L 2004 Coating of mannan on LPD particles containing HPV E7 peptide significantly enhances immunity against HPV-positive tumor Pharm. Res. 21 1018-25 (Pubitemid 38870153)
47. Yeeprae W, Kawakami S, Yamashita F and Hashida M 2006 Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated O/W emulsions by macrophages J. Control Release 114 193-201 (Pubitemid 44291840)
48. Jain S and Vyas S P 2006 Mannosylated niosomes as adjuvant-carrier system for oral mucosal immunization J. Liposome Res. 16 331-45 (Pubitemid 44949884)
49. Apostolopoulos V et al 2006 Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835] Breast Cancer Res. 8 R27 (Pubitemid 43899331)
50. Diwan M, Elamanchili P, Cao M and Samuel J 2004 Dose sparing of CpG oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery Curr. Drug. Deliv. 1 405-12
51. Hamdy S, Haddadi A, Shayeganpour A, Samuel J and Lavasanifar A 2011 Activation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticles Pharm. Res. 28 2288-301